Key facts
- This page summarizes James A. Robinson Jr.'s Form 4 filing for UroGen Pharma Ltd. (URGN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2026, 08:04.
James A. Robinson Jr. - 26 May 2026 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)
- Reporting relationship
- Director
- Issuer ticker
- URGN
- Reported as of
- 26 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 May 2026, 08:04:51 UTC
- Prior SEC filing
- 27 Feb 2026
- Next SEC filing
- 24 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason D. Smith, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
James A. Robinson Jr. filed Form 4 for UroGen Pharma Ltd. (URGN) on 27 May 2026.
Change
- Previous filing in this sequence was filed on 27 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001734295
Primary reporting owner
Robinson James A. Jr.
- Relationship
- Director
- Address
- 400 ALEXANDER PARK DRIVE, PRINCETON
- Signature
- /s/ Jason D. Smith, Attorney-in-Fact
- Signature date
- 27 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
URGN
transaction
ordinary shares
Options Exercise
- Transaction value
- Shares
- +2,000
- Change %
- +50%
- Price
- Shares after
- 6,000
- Date
- 26 May 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
URGN
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -2,000
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 2,000
- Date
- 26 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,000
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer